Your Control Tower Can See the Problem. It Still Cannot Fix It.
The Cost of Seeing Without Acting
Visibility platforms surface exceptions but leave resolution to people. These numbers show what that gap costs and what closing it looks like.

A cell therapy shipment is en route from a manufacturing site in Los Angeles to a clinical site in Kansas City. The courier hasn't updated the tracking portal since pickup. The flight that was supposed to carry the package has been delayed. The clinical team at the receiving site has a patient scheduled.
The logistics coordinator, checking the control tower dashboard, can see the delay. What happens next is entirely manual. Someone calls the courier's operations line, waits on hold, escalates, potentially sources an alternative solution, calls the site to manage expectations, and documents the deviation in the quality management system. All of this happens while the product's viability window continues to close.
The dashboard didn't solve the problem. It just made the problem visible.
A decade of better dashboards
The term "control tower" entered healthcare logistics roughly fifteen years ago, borrowed from aerospace and general freight. The concept was straightforward: instead of checking multiple carrier portals and two sensor dashboards, data would be aggregated into a consolidated view. For a small team managing a few hundred shipments a month, this was transformative. For a team managing tens of thousands of shipments across multiple couriers, sensor vendors, clinical trial sites, and patients, the consolidated view has become the floor, not the ceiling.
The past decade of logistics platforms promised to transform pharmaceutical and healthcare supply chain operations. Most delivered a better dashboard. Some delivered predictive risk models. What they have not delivered is fewer phone calls, fewer escalations, and fewer missed deliveries. The problem is structural: aggregation and action are two different things. A consolidated view of a flight delay still requires a human to gather options, weigh them against risk, time, cost, contractual obligations or quality procedures and decide what to do, and then make the call, send the email, and log the outcome.
Why this matters now
Cold chain failures cost the pharmaceutical industry an estimated $35 billion a year, spanning product loss, clinical trial replacement costs, wasted logistics spend, and root-cause analysis. Yet exception management still scales with headcount: 20% more shipments demand roughly 20% more coordinators, in a market where experienced ones are scarce and expensive. This is why the zero-touch rate from Part 2 sits at zero for most teams: the tools were never built to move it in the right direction.
"In healthcare and life sciences, a logistics failure isn't a supply chain problem. It's patient safety. AI fused into the orchestration layer can now close the loop on exceptions autonomously, with a full audit trail. It's a different operating model entirely."
Chris McDonald – Former SVP & Head of global technical operations, Kite (Gilead company)
A new generation of AI-native platforms is closing the gap between seeing a problem and fixing it: voice agents that call courier operations lines, email agents that notify sites and recipients, and no-code workflows that turn SOPs into executed, audited sequences. Whether that claim holds up, and how to tell the difference between real capability and rebranded dashboards, is where this series goes next.
Next week: when a system fires hundreds of alerts a day, how do teams decide which ones to focus on? Read the full white paper at zoomlogi.com/white-paper/not-another-control-tower.